Publications
720
Citations
16,840
Est. group size
~1
Recurring co-author estimate
Active years
28
Publishing since 1999
Kathryn L. Terry studies ovarian cancer, focusing on risk factors, hormone exposures (like oral contraceptives and hormone therapy), and how the immune system within tumors relates to patient survival. Her work also touches on related conditions such as endometriosis and reproductive health factors like IVF outcomes. Much of this research uses large collaborative datasets and consortiums to study cancer risk and outcomes across many patients.
Publication output was fairly steady at 20-30 papers per year through 2022, then spiked sharply in 2023 before declining somewhat in subsequent years, suggesting a period of unusually high collaborative or consortium-driven output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
Cancer Epidemiology Biomarkers & Prevention · 2026
- Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis
Gynecologic Oncology · 2026
- Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use
British Journal of Cancer · 2026
- Endometriosis First Diagnosed After Menopause: A Prospective Cohort Study
SSRN Electronic Journal · 2026
- Follicular fluid per- and polyfluoroalkyl substances, metabolomics, and live birth after in vitro fertilization: a pilot study
F&S Science · 2026
- Abstract 6261: Inflammation-related exposures and histotype- specific ovarian cancer risk in the Ovarian Cancer Association Consortium (OCAC).
Cancer Research · 2026
- Abstract 6844: Functional data analysis of spatial protein imaging data using spatial trajectories with application to ovarian cancer.
Cancer Research · 2026
- Abstract 2317: Plasma metabolomic profiles of oral contraception use associated with breast and ovarian cancers among premenopausal women in Nurse’s Health Study II
Cancer Research · 2026
- Abstract 6851: Multi-cell type model for analyzing spatial single-cell protein imaging data with application to ovarian cancer.
Cancer Research · 2026
- Supplementary Table 4 from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Supplementary Table 2 from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Supplementary Table 3 from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Data from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Supplementary Table 1 from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Supplementary Table 5 from Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
2026
- Cancer Research×32
- Cancer Epidemiology Biomarkers & Prevention×25
- Clinical Cancer Research×14
- Fertility and Sterility×12
- International Journal of Cancer×11
- Mary Johnston
Medicine · Indiana University
- Robert Neff
Medicine · The Ohio State University
- Larry J. Copeland
Medicine · The Ohio State University
- Laura Chambers
Medicine · The Ohio State University
- D. E. Cohn
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile